伊奧尼斯製藥 IONS 深 滬
等待開盤 07-02 09:30:00 美东时间
79.19
-0.100
-0.13%
華盛通- 最 高79.48
- 今 開79.13
- 成交量 144.24万股
- 最 低 77.95
- 昨 收 79.29
- 總市值 130.87亿
- 52周最高 86.74
- 市盈率 靜 --
- 換手率 0.87%
- 52周最低 40.03
- 委 比 94.70%
- 總股本 1.65亿
- 歷史最高 86.74
- 量 比 0.51
- 振 幅 1.93%
- 歷史最低 6.25
- 每 手 1
- 風險率 13.56%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多阿斯利康预计凭借Eplontersen及管线产品到2030年实现180亿美元市场规模
杰富瑞重申阿斯利康（AZN）“买入”评级，在心脏药物eplontersen用于转甲状腺素蛋白淀粉样变性的CARDIO-TTRansform三期试验数据公布前，将...
06-26 20:19
美股大行评级 | 潜在涨幅135.66%！Ocular Therapeutix获Chardan Capital升目标价至23美元，维持"买入"评级
今日重点评级关注：Chardan Capital：维持Ocular Therapeutix"买入"评级，目标价从21美元升至23美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从30美元升至40美元
06-26 17:42
Ionis, Recordati inks ex-U.S. license deal for Zilganerse
Ionis Pharmaceuticals (IONS) Wednesday reported that it has entered into a license agreement with Recordati, under which Recordati obtained exclusive rights to develop and commercialize zilganersen, a...
06-25 16:06
Ionis Pharmaceuticals Announces License Agreement With Recordati For Zilganersen In Alexander Disease In All Countries Outside The US For $30M Upfront Payment
Ionis Pharmaceuticals Announces License Agreement With Recordati For Zilganersen In Alexander Disease In All Countries Outside The US For $30M Upfront Payment
06-25 15:27
Ionis licenses Alexander disease drug zilganersen to Recordati outside US for $30 million upfront
Ionis licenses Alexander disease drug zilganersen to Recordati outside US for $30 million upfront Ionis signed a license deal with Recordati granting exclusive rights to develop and commercialize zilganersen for Alexander disease outside the U.S. Ionis kept U.S. commercialization rights, will lead g
06-25 14:59
Ionis gains additional Tryngolza indication
The US FDA has approved an indicational indication for Ionis Pharmaceuticals' (IONS) Tryngolza (olezarsen) to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyc...
06-25 04:18
Ionis wins FDA approval for TRYNGOLZA triglyceride therapy
The latest update is out from Ionis Pharmaceuticals ( ($IONS) ). On June 24, 20...
06-25 04:17
美股大行评级 | 花旗维持美光科技"买入"评级！目标价从840美元升至1200美元
今日重点评级关注：Chardan Capital：维持SAB Biotherapeutics"买入"评级，目标价从14美元升至16美元；Northland Capital Markets：维持Applied Digital"跑赢大市"评级，目标价从56美元升至82美元
06-18 19:08
美股夜盘 | SpaceX涨14.67%，回声星通信涨2.98%
SpaceX涨14.67%；回声星通信涨2.98%；Magnolia Oil & Gas Corp. Class A涨2.88%
06-16 09:01
